Page 169 - Traité de Chimie Thérapeutique 4 Médicaments en relation avec des systèmes hormonaux

130 MÉDICAMENTS EN RELATION AVEC DES SYSTÈMES HORMONAUX

BIBLIOGRAPHIE
Articles généraux
LAURENS A., GIONO-BARBER P., SYLLA O. et GIONO-BARBER H., Les inhibiteurs
de l’aldose réductase. Thérapie, 1983, 38, 659-663.
KADOR F.K., KINOSHITA J.H. et SHARPLESS N.E., Aldose reductase inhibitor : a
potential new class of agents for the pharmacological control of certain diabetic
complications, J. Med. Chem., 1985, 28, 841-849.
DOSTERT P. et STROLIN BENEDETTI M., Les inhibiteurs de l’aldose réductase.
J. Pharmacol (Paris),1986,17, 483-496.
KADOR P.F., ROBISON W.G. Jr et KINOSHITA J.H., The pharmacology of aldose
reductase inhibitors. Ann. Rev. Pharmacol. Toxicol., 1985, 25, 691-714.
LARSON E.R., LIPINSKI C.A. et SARGES R., Médicinal chemistry of aldose reductase
inhibitors. Médicinal Research Reviews, 1988, 8, 159-186.
KADOR P.F., The rôle of aldose reductase in the development of diabetic complica­
tions. Médicinal Research Reviews, 1988, 8, 325-352.
Spirohydantoïnes, sorbinil
SARGES R., BORDNER J., DOMINY B.W., PETERSON M.J. et WHIPPLE E.B.,
Synthesis, absolute configuration and conformation of the aldose reductase inhibi­
tor sorbinil. J. Med. Chem.,1985, 28,1716-1720.
SARGES R., SCHNUR R.C., BELLETIRE J.L. et PETERSON M.J., Spirohydantoin
aldose reductase inhibitors, J. Med. Chem.,1988, 31, 230-243.
DICK P.J., ZIMMERMAN B.R., VILEN T.H., MINNERATI S.R., KARNES J.L., YAO
J.K. et PODUSLO J.F., Nerve glucose, fructose, sorbitol, myo-inositol and fiber
degeneration and régénération in diabetic neuropathy. N. Eng. J. Med., 1988, 39,
542-548.
SIMA A.A.F., BRIL V., NATHANIEL V., McEWEN T.A.J., BROWN M.B., LATTIMER
S.A. et GREENE D.A., Régénération and repair of myelinated fibers in sural-nerve
biopsy specimens from patients with diabetic neuropathy treated with sorbinil.
N. Eng. J. Med.,1988, 39, 548-555.
PITTS N.E., VREELAND F., SHAW G.L., PETERSON M.J., MEHTA D. J, COLLIER
J. et GUNDERSEN K., Clinical expérience with sorbinil -an aldose reductase inhibi­
tor. Metabolism, 1986, 35, 96-100.
Analogues du sorbinil
BOVY P., LENAERS A., CALLAERT M., HERICKX N., GILLET C., ROBA J., DETHY
J.M., CALLAERT-DEVEEN B. et JANSSENS M. Synthesis and aldose reductase
inhibition activity of spiro [9H-fluoren-9,4'-imidazolidine]-2',5’-dione dérivatives.
Eur. J. Med. Chem., 1988, 23, 165-172.
SARGES R.. GOLDSTEIN S.W., WELCH W.M., SWINDELL A.C., SIEGEL
T.W. et BEYER T.A., Spiro hydantoin aldose reductase inhibitors derived from 8-
aza-4-chromanones. J. Med. Chem., 1990, 33, 1859-1865.
DU PRIEST M.T., GRIFFIN B.W., KUZMICH D. et Mc NATT L.G. Spiro[fluoreneisothia-
zolidinjone dioxides : new aldose reductase and L-hexonate dehydrogenase inhibi­
tors. J. Med. Chem., 1991, 34, 3229-3234.